Medidata has announced a partnership with CRIO. The collaboration is driving high data quality standards and efficiencies at over 2,500 research sites across about 30 countries by bridging the gap between clinical site operations and global data management. This partnership delivers a “plug-and-play” digital pipeline that automates the transfer of clinical data from CRIO eSource directly into the Medidata Platform, which supports the Medidata Data, Study and Patient Experiences, removing the technical complexity and high costs of custom configurations. The collaboration has moved beyond simple connectivity to deliver industry-leading performance benchmarks: Near 100% Data Accuracy: Automated “source-to-EDC” transfer supports data integrity, resulting in a dramatic reduction in queries and data changes. 90% Faster Data Entry: Sites can now auto-populate EDC forms with source data, reducing data entry time. Broad Market Footprint: One in four US research sites engaged in chronic condition trials now leverage the CRIO-Medidata ecosystem
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DASTY:
- Dassault Systemes downgraded to Neutral from Buy at Goldman Sachs
- Leadership Transition Risks and Constrained Transformation Capacity Underpin Sell Rating on Dassault Systèmes
- Dassault Systemes price target lowered to EUR 19 from EUR 26 at Citi
- Dassault Systemes price target lowered to EUR 21 from EUR 26 at JPMorgan
- Dassault Systemes price target lowered to EUR 28.25 at Morgan Stanley
